Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc112_10, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 10 input genes in category / 26 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0003729 mRNA binding 1.861E-8 4.839E-7 1.865E-6 4.839E-7 5 179
2 GO:0003730 mRNA 3'-UTR binding 2.415E-6 3.140E-5 1.210E-4 6.280E-5 3 52
3 GO:0003727 single-stranded RNA binding 9.249E-6 8.016E-5 3.090E-4 2.405E-4 3 81
4 GO:0017124 SH3 domain binding 3.242E-5 2.107E-4 8.122E-4 8.429E-4 3 123
5 GO:0003697 single-stranded DNA binding 1.345E-3 6.963E-3 2.684E-2 3.496E-2 2 104
6 GO:1990829 C-rich single-stranded DNA binding 1.607E-3 6.963E-3 2.684E-2 4.178E-2 1 3
7 GO:0033592 RNA strand annealing activity 2.142E-3 7.956E-3 3.067E-2
5.569E-2
1 4
8 GO:0002151 G-quadruplex RNA binding 3.746E-3 1.217E-2 4.692E-2
9.739E-2
1 7
9 GO:0048027 mRNA 5'-UTR binding 5.880E-3 1.668E-2
6.427E-2
1.529E-1
1 11
10 GO:0097617 annealing activity 6.413E-3 1.668E-2
6.427E-2
1.668E-1
1 12
11 GO:0008143 poly(A) binding 9.075E-3 2.081E-2
8.022E-2
2.359E-1
1 17
12 GO:0008266 poly(U) RNA binding 9.606E-3 2.081E-2
8.022E-2
2.498E-1
1 18
13 GO:0008187 poly-pyrimidine tract binding 1.173E-2 2.277E-2
8.776E-2
3.050E-1
1 22
14 GO:0017091 AU-rich element binding 1.226E-2 2.277E-2
8.776E-2
3.188E-1
1 23
15 GO:0070717 poly-purine tract binding 1.332E-2 2.309E-2
8.899E-2
3.463E-1
1 25
16 GO:0001205 distal enhancer DNA-binding transcription activator activity, RNA polymerase II-specific 1.596E-2 2.594E-2
9.999E-2
4.151E-1
1 30
17 GO:0045182 translation regulator activity 2.229E-2 3.408E-2
1.314E-1
5.794E-1
1 42
18 GO:0005070 SH3/SH2 adaptor activity 2.857E-2 4.127E-2
1.591E-1
7.428E-1
1 54
19 GO:0003725 double-stranded RNA binding 3.586E-2 4.907E-2
1.891E-1
9.323E-1
1 68
Show 14 more annotations

2: GO: Biological Process [Display Chart] 10 input genes in category / 198 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0017148 negative regulation of translation 6.521E-9 5.828E-7 3.420E-6 1.291E-6 5 145
2 GO:0006417 regulation of translation 7.905E-9 5.828E-7 3.420E-6 1.565E-6 6 347
3 GO:0034249 negative regulation of cellular amide metabolic process 8.830E-9 5.828E-7 3.420E-6 1.748E-6 5 154
4 GO:0034248 regulation of cellular amide metabolic process 1.360E-8 6.733E-7 3.951E-6 2.693E-6 6 380
5 GO:0010608 posttranscriptional regulation of gene expression 5.138E-8 2.035E-6 1.194E-5 1.017E-5 6 475
6 GO:0006403 RNA localization 3.373E-6 1.113E-4 6.531E-4 6.678E-4 4 214
7 GO:0061157 mRNA destabilization 2.354E-5 6.657E-4 3.906E-3 4.660E-3 2 14
8 GO:0050779 RNA destabilization 3.514E-5 8.698E-4 5.104E-3 6.958E-3 2 17
9 GO:0006397 mRNA processing 8.025E-5 1.728E-3 1.014E-2 1.589E-2 4 479
10 GO:0050658 RNA transport 9.971E-5 1.728E-3 1.014E-2 1.974E-2 3 179
11 GO:0050657 nucleic acid transport 9.971E-5 1.728E-3 1.014E-2 1.974E-2 3 179
12 GO:0051236 establishment of RNA localization 1.048E-4 1.728E-3 1.014E-2 2.074E-2 3 182
13 GO:0050688 regulation of defense response to virus 1.344E-4 2.048E-3 1.202E-2 2.662E-2 3 198
14 GO:0015931 nucleobase-containing compound transport 1.715E-4 2.426E-3 1.423E-2 3.396E-2 3 215
15 GO:0002831 regulation of response to biotic stimulus 2.901E-4 3.830E-3 2.247E-2
5.745E-2
3 257
16 GO:0051607 defense response to virus 6.751E-4 8.354E-3 4.902E-2
1.337E-1
3 343
17 GO:0008380 RNA splicing 1.070E-3 1.181E-2
6.930E-2
2.119E-1
3 402
18 GO:0046833 positive regulation of RNA export from nucleus 1.074E-3 1.181E-2
6.930E-2
2.126E-1
1 2
19 GO:0009615 response to virus 1.283E-3 1.337E-2
7.843E-2
2.539E-1
3 428
20 GO:0010609 mRNA localization resulting in posttranscriptional regulation of gene expression 1.610E-3 1.475E-2
8.653E-2
3.188E-1
1 3
21 GO:0032241 positive regulation of nucleobase-containing compound transport 1.610E-3 1.475E-2
8.653E-2
3.188E-1
1 3
22 GO:0002697 regulation of immune effector process 1.638E-3 1.475E-2
8.653E-2
3.244E-1
3 466
23 GO:1900245 positive regulation of MDA-5 signaling pathway 2.146E-3 1.848E-2
1.084E-1
4.250E-1
1 4
24 GO:0043488 regulation of mRNA stability 2.565E-3 2.116E-2
1.242E-1
5.080E-1
2 144
25 GO:0043487 regulation of RNA stability 2.707E-3 2.144E-2
1.258E-1
5.361E-1
2 148
26 GO:0051028 mRNA transport 2.816E-3 2.145E-2
1.258E-1
5.576E-1
2 151
27 GO:0039533 regulation of MDA-5 signaling pathway 3.218E-3 2.360E-2
1.385E-1
6.372E-1
1 6
28 GO:0075522 IRES-dependent viral translational initiation 3.753E-3 2.654E-2
1.557E-1
7.432E-1
1 7
29 GO:0051151 negative regulation of smooth muscle cell differentiation 4.289E-3 2.654E-2
1.557E-1
8.491E-1
1 8
30 GO:0061158 3'-UTR-mediated mRNA destabilization 4.289E-3 2.654E-2
1.557E-1
8.491E-1
1 8
31 GO:0001955 blood vessel maturation 4.289E-3 2.654E-2
1.557E-1
8.491E-1
1 8
32 GO:1900246 positive regulation of RIG-I signaling pathway 4.289E-3 2.654E-2
1.557E-1
8.491E-1
1 8
33 GO:0006413 translational initiation 4.598E-3 2.759E-2
1.619E-1
9.105E-1
2 194
34 GO:0039530 MDA-5 signaling pathway 4.823E-3 2.809E-2
1.648E-1
9.550E-1
1 9
35 GO:0019081 viral translation 5.358E-3 3.031E-2
1.779E-1
1.000E0
1 10
36 GO:0042759 long-chain fatty acid biosynthetic process 5.892E-3 3.153E-2
1.850E-1
1.000E0
1 11
37 GO:0008298 intracellular mRNA localization 5.892E-3 3.153E-2
1.850E-1
1.000E0
1 11
38 GO:0002192 IRES-dependent translational initiation of linear mRNA 6.427E-3 3.263E-2
1.915E-1
1.000E0
1 12
39 GO:0046831 regulation of RNA export from nucleus 6.427E-3 3.263E-2
1.915E-1
1.000E0
1 12
40 GO:2000637 positive regulation of gene silencing by miRNA 6.960E-3 3.361E-2
1.972E-1
1.000E0
1 13
41 GO:0039535 regulation of RIG-I signaling pathway 6.960E-3 3.361E-2
1.972E-1
1.000E0
1 13
42 GO:0032239 regulation of nucleobase-containing compound transport 7.494E-3 3.451E-2
2.025E-1
1.000E0
1 14
43 GO:0060148 positive regulation of posttranscriptional gene silencing 7.494E-3 3.451E-2
2.025E-1
1.000E0
1 14
44 GO:0002190 cap-independent translational initiation 8.027E-3 3.532E-2
2.073E-1
1.000E0
1 15
45 GO:0039531 regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway 8.027E-3 3.532E-2
2.073E-1
1.000E0
1 15
46 GO:0039529 RIG-I signaling pathway 8.560E-3 3.685E-2
2.162E-1
1.000E0
1 16
47 GO:0002183 cytoplasmic translational initiation 9.093E-3 3.831E-2
2.248E-1
1.000E0
1 17
48 GO:0039703 RNA replication 1.016E-2 3.944E-2
2.314E-1
1.000E0
1 19
49 GO:0050687 negative regulation of defense response to virus 1.016E-2 3.944E-2
2.314E-1
1.000E0
1 19
50 GO:0048714 positive regulation of oligodendrocyte differentiation 1.016E-2 3.944E-2
2.314E-1
1.000E0
1 19
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 10 input genes in category / 21 annotations before applied cutoff / 19061 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0005844 polysome 2.875E-4 5.509E-3 2.008E-2 6.038E-3 2 49
2 GO:0070618 Grb2-Sos complex 5.246E-4 5.509E-3 2.008E-2 1.102E-2 1 1

4: Human Phenotype [Display Chart] 0 input genes in category / 0 annotations before applied cutoff / 4707 genes in category

No results to display

5: Mouse Phenotype [Display Chart] 8 input genes in category / 211 annotations before applied cutoff / 10355 genes in category

No results to display

6: Domain [Display Chart] 10 input genes in category / 48 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 PF00013 KH 1 Pfam 3.228E-28 6.945E-27 3.097E-26 1.549E-26 10 38
2 3.30.1370.10 - Gene3D 4.341E-28 6.945E-27 3.097E-26 2.084E-26 10 39
3 SM00322 KH SMART 5.788E-28 6.945E-27 3.097E-26 2.778E-26 10 40
4 IPR004087 KH dom InterPro 5.788E-28 6.945E-27 3.097E-26 2.778E-26 10 40
5 PS50084 KH TYPE 1 PROSITE 1.005E-27 9.645E-27 4.300E-26 4.822E-26 10 42
6 IPR004088 KH dom type 1 InterPro 1.694E-27 1.355E-26 6.043E-26 8.132E-26 10 44
7 IPR032172 FXR C1 InterPro 2.564E-7 1.539E-6 6.860E-6 1.231E-5 2 2
8 PF16096 FXR C1 Pfam 2.564E-7 1.539E-6 6.860E-6 1.231E-5 2 2
9 IPR032335 Sam68-YY InterPro 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
10 IPR022034 FXMRP1 C core InterPro 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
11 PS51641 AGENET LIKE PROSITE 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
12 PF05641 Agenet Pfam 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
13 PF16568 Sam68-YY Pfam 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
14 IPR008395 Agenet-like dom InterPro 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
15 PF16274 Qua1 Pfam 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
16 PF12235 FXMRP1 C core Pfam 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
17 IPR032571 Qua1 dom InterPro 7.691E-7 2.171E-6 9.682E-6 3.691E-5 2 3
18 PF16544 STAR dimer Pfam 5.338E-4 1.114E-3 4.967E-3 2.562E-2 1 1
19 PF16097 FXR C3 Pfam 5.338E-4 1.114E-3 4.967E-3 2.562E-2 1 1
20 IPR032177 FXR C3 InterPro 5.338E-4 1.114E-3 4.967E-3 2.562E-2 1 1
21 IPR032367 Quaking NLS InterPro 5.338E-4 1.114E-3 4.967E-3 2.562E-2 1 1
22 PF16551 Quaking NLS Pfam 5.338E-4 1.114E-3 4.967E-3 2.562E-2 1 1
23 IPR032377 STAR dimer InterPro 5.338E-4 1.114E-3 4.967E-3 2.562E-2 1 1
24 PF09005 DUF1897 Pfam 1.067E-3 2.049E-3 9.137E-3
5.123E-2
1 2
25 IPR015096 DUF1897 InterPro 1.067E-3 2.049E-3 9.137E-3
5.123E-2
1 2
26 IPR009019 KH prok-type InterPro 2.134E-3 3.939E-3 1.756E-2
1.024E-1
1 4
Show 21 more annotations

7: Pathway [Display Chart] 7 input genes in category / 13 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1383030 PTK6 Regulates Proteins Involved in RNA Processing BioSystems: REACTOME 2.708E-6 3.520E-5 1.119E-4 3.520E-5 2 5
2 1457786 Signaling by BRAF and RAF fusions BioSystems: REACTOME 4.881E-4 2.461E-3 7.825E-3 6.346E-3 2 61
3 1383025 Signaling by PTK6 BioSystems: REACTOME 6.065E-4 2.461E-3 7.825E-3 7.884E-3 2 68
4 1457781 Oncogenic MAPK signaling BioSystems: REACTOME 7.571E-4 2.461E-3 7.825E-3 9.843E-3 2 76
5 1269733 Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA BioSystems: REACTOME 1.686E-3 4.383E-3 1.394E-2 2.192E-2 1 3
6 177876 RNA transport BioSystems: KEGG 3.764E-3 8.156E-3 2.594E-2 4.893E-2 2 171
7 1268855 Diseases of signal transduction BioSystems: REACTOME 1.701E-2 3.160E-2
1.005E-1
2.212E-1
2 373
8 1269264 Negative regulators of RIG-I/MDA5 signaling BioSystems: REACTOME 2.007E-2 3.218E-2
1.023E-1
2.609E-1
1 36
9 1510435 Ferroptosis BioSystems: KEGG 2.228E-2 3.218E-2
1.023E-1
2.896E-1
1 40
Show 4 more annotations

8: Pubmed [Display Chart] 10 input genes in category / 1011 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 16033648 A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain. Pubmed 3.870E-16 3.913E-13 2.933E-12 3.913E-13 8 285
2 9433137 STAR, a gene family involved in signal transduction and activation of RNA. Pubmed 1.292E-11 6.533E-9 4.898E-8 1.307E-8 3 3
3 12529443 Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Pubmed 2.584E-10 8.708E-8 6.528E-7 2.612E-7 3 6
4 28977470 The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. Pubmed 4.344E-8 5.671E-6 4.251E-5 4.392E-5 4 147
5 9315629 Self-association of the single-KH-domain family members Sam68, GRP33, GLD-1, and Qk1: role of the KH domain. Pubmed 6.170E-8 5.671E-6 4.251E-5 6.238E-5 2 2
6 11735223 Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. Pubmed 6.170E-8 5.671E-6 4.251E-5 6.238E-5 2 2
7 10564820 Salpalpha and Salpbeta, growth-arresting homologs of Sam68. Pubmed 6.170E-8 5.671E-6 4.251E-5 6.238E-5 2 2
8 26758068 Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68. Pubmed 6.170E-8 5.671E-6 4.251E-5 6.238E-5 2 2
9 21072162 Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2. Pubmed 6.170E-8 5.671E-6 4.251E-5 6.238E-5 2 2
10 9259278 Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. Pubmed 6.170E-8 5.671E-6 4.251E-5 6.238E-5 2 2
11 10196376 Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Pubmed 6.170E-8 5.671E-6 4.251E-5 6.238E-5 2 2
12 22365833 Dynamic protein-protein interaction wiring of the human spliceosome. Pubmed 1.407E-7 6.683E-6 5.009E-5 1.423E-4 4 197
13 25496916 A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. Pubmed 1.823E-7 6.683E-6 5.009E-5 1.843E-4 3 45
14 28767039 FXR1 regulates transcription and is required for growth of human cancer cells with Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
15 27770568 Sub-synaptic, multiplexed analysis of proteins reveals Fragile X related protein 2 is mislocalized in Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
16 21957233 FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
17 19254361 Inhibition of HIV-1 gene expression by Sam68 Delta C: multiple targets but a common mechanism? Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
18 8668200 Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
19 20442204 Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
20 7489725 The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
21 18589395 Fragile X-related proteins regulate mammalian circadian behavioral rhythms. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
22 28204491 Fragile X related protein 1 (FXR1P) regulates proliferation of adult neural stem cells. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
23 16474851 The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
24 19487368 Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
25 26612855 Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
26 11157796 Evidence that fragile X mental retardation protein is a negative regulator of translation. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
27 19091369 Mapping of determinants involved in the stimulation of HIV-1 expression by Sam68. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
28 10888599 The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins. Pubmed 1.851E-7 6.683E-6 5.009E-5 1.871E-4 2 3
29 16571602 The nuclear microspherule protein 58 is a novel RNA-binding protein that interacts with fragile X mental retardation protein in polyribosomal mRNPs from neurons. Pubmed 3.701E-7 1.100E-5 8.250E-5 3.742E-4 2 4
30 15471878 The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. Pubmed 3.701E-7 1.100E-5 8.250E-5 3.742E-4 2 4
31 18664458 Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP. Pubmed 3.701E-7 1.100E-5 8.250E-5 3.742E-4 2 4
32 10567518 Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Pubmed 3.701E-7 1.100E-5 8.250E-5 3.742E-4 2 4
33 10556305 A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein. Pubmed 3.701E-7 1.100E-5 8.250E-5 3.742E-4 2 4
34 22196734 SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. Pubmed 3.701E-7 1.100E-5 8.250E-5 3.742E-4 2 4
35 10077576 Characterization of Sam68-like mammalian proteins SLM-1 and SLM-2: SLM-1 is a Src substrate during mitosis. Pubmed 6.167E-7 1.782E-5 1.335E-4 6.235E-4 2 5
36 26777405 ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. Pubmed 9.168E-7 2.398E-5 1.798E-4 9.269E-4 4 315
37 18321792 Dynamic expression of the RNA-binding protein Sam68 during mouse pre-implantation development. Pubmed 9.250E-7 2.398E-5 1.798E-4 9.352E-4 2 6
38 11438699 A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Pubmed 9.250E-7 2.398E-5 1.798E-4 9.352E-4 2 6
39 25145264 Formation of nuclear bodies by the lncRNA Gomafu-associating proteins Celf3 and SF1. Pubmed 9.250E-7 2.398E-5 1.798E-4 9.352E-4 2 6
40 8871564 The mouse poly(C)-binding protein exists in multiple isoforms and interacts with several RNA-binding proteins. Pubmed 1.295E-6 3.193E-5 2.393E-4 1.309E-3 2 7
41 11118435 The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites. Pubmed 1.295E-6 3.193E-5 2.393E-4 1.309E-3 2 7
42 24778252 TRIM65 regulates microRNA activity by ubiquitination of TNRC6. Pubmed 1.629E-6 3.921E-5 2.939E-4 1.647E-3 4 364
43 23974796 Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. Pubmed 1.726E-6 4.058E-5 3.042E-4 1.745E-3 2 8
44 17643375 Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Pubmed 2.142E-6 4.921E-5 3.689E-4 2.165E-3 4 390
45 10332027 T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis. Pubmed 2.773E-6 6.231E-5 4.671E-4 2.804E-3 2 10
46 22022532 Fragile X related protein 1 clusters with ribosomes and messenger RNAs at a subset of dendritic spines in the mouse hippocampus. Pubmed 3.389E-6 7.290E-5 5.465E-4 3.427E-3 2 11
47 29142209 Fbxo4-mediated degradation of Fxr1 suppresses tumorigenesis in head and neck squamous cell carcinoma. Pubmed 3.389E-6 7.290E-5 5.465E-4 3.427E-3 2 11
48 10749975 RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing. Pubmed 4.805E-6 1.012E-4 7.587E-4 4.858E-3 2 13
49 23979707 SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers. Pubmed 1.071E-5 2.209E-4 1.656E-3 1.082E-2 3 173
50 20975687 TERRA transcripts are bound by a complex array of RNA-binding proteins. Pubmed 1.698E-5 3.433E-4 2.573E-3 1.716E-2 2 24
Show 45 more annotations

9: Interaction [Display Chart] 10 input genes in category / 863 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:WDR77 WDR77 interactions 2.029E-9 1.751E-6 1.285E-5 1.751E-6 6 263
2 int:PTBP2 PTBP2 interactions 3.352E-7 1.446E-4 1.061E-3 2.893E-4 3 26
3 int:RBMX RBMX interactions 1.326E-6 3.492E-4 2.563E-3 1.145E-3 4 161
4 int:PCBP1 PCBP1 interactions 1.619E-6 3.492E-4 2.563E-3 1.397E-3 5 417
5 int:AGO1 AGO1 interactions 3.171E-6 4.680E-4 3.434E-3 2.737E-3 3 54
6 int:CLEC14A CLEC14A interactions 3.353E-6 4.680E-4 3.434E-3 2.894E-3 3 55
7 int:HNRNPK HNRNPK interactions 3.796E-6 4.680E-4 3.434E-3 3.276E-3 5 496
8 int:FUBP3 FUBP3 interactions 6.965E-6 7.514E-4 5.514E-3 6.011E-3 3 70
9 int:SPATA13 SPATA13 interactions 1.890E-5 1.812E-3 1.330E-2 1.631E-2 2 12
10 int:KHDRBS2 KHDRBS2 interactions 2.294E-5 1.980E-3 1.453E-2 1.980E-2 3 104
11 int:PCBP2 PCBP2 interactions 2.788E-5 2.187E-3 1.605E-2 2.406E-2 3 111
12 int:AGO2 AGO2 interactions 3.100E-5 2.229E-3 1.636E-2 2.675E-2 3 115
13 int:CCDC58 CCDC58 interactions 3.888E-5 2.581E-3 1.894E-2 3.356E-2 2 17
14 int:U2AF2 U2AF2 interactions 4.563E-5 2.813E-3 2.064E-2 3.938E-2 4 394
15 int:BMI1 BMI1 interactions 5.230E-5 3.009E-3 2.208E-2 4.513E-2 4 408
16 int:G3BP1 G3BP1 interactions 7.144E-5 3.853E-3 2.828E-2
6.165E-2
4 442
17 int:SRSF3 SRSF3 interactions 7.845E-5 3.982E-3 2.922E-2
6.770E-2
3 157
18 int:DMRT2 DMRT2 interactions 8.556E-5 3.983E-3 2.923E-2
7.384E-2
2 25
19 int:GSK3A GSK3A interactions 8.770E-5 3.983E-3 2.923E-2
7.568E-2
3 163
20 int:CYFIP1 CYFIP1 interactions 1.177E-4 5.079E-3 3.727E-2
1.016E-1
3 180
21 int:HNRNPC HNRNPC interactions 1.469E-4 5.893E-3 4.324E-2
1.268E-1
3 194
22 int:DMRTB1 DMRTB1 interactions 1.502E-4 5.893E-3 4.324E-2
1.296E-1
2 33
23 int:TDRD3 TDRD3 interactions 1.997E-4 7.494E-3
5.499E-2
1.724E-1
2 38
24 int:PRMT1 PRMT1 interactions 2.652E-4 9.014E-3
6.615E-2
2.289E-1
3 237
25 int:KHDRBS3 KHDRBS3 interactions 2.807E-4 9.014E-3
6.615E-2
2.422E-1
2 45
26 int:NCOA5 NCOA5 interactions 2.807E-4 9.014E-3
6.615E-2
2.422E-1
2 45
27 int:CD81 CD81 interactions 2.820E-4 9.014E-3
6.615E-2
2.434E-1
3 242
28 int:PPP1R13B PPP1R13B interactions 3.608E-4 1.112E-2
8.160E-2
3.114E-1
2 51
29 int:RBM23 RBM23 interactions 3.751E-4 1.116E-2
8.192E-2
3.237E-1
2 52
30 int:NELFB NELFB interactions 3.897E-4 1.121E-2
8.227E-2
3.363E-1
2 53
31 int:MIA3 MIA3 interactions 4.197E-4 1.168E-2
8.574E-2
3.622E-1
2 55
32 int:PSMF1 PSMF1 interactions 4.351E-4 1.174E-2
8.611E-2
3.755E-1
2 56
33 int:SLAIN2 SLAIN2 interactions 4.668E-4 1.217E-2
8.929E-2
4.028E-1
2 58
34 int:FMR1 FMR1 interactions 4.794E-4 1.217E-2
8.929E-2
4.137E-1
3 290
35 int:RBM7 RBM7 interactions 4.995E-4 1.232E-2
9.038E-2
4.311E-1
2 60
36 int:CAPRIN1 CAPRIN1 interactions 5.861E-4 1.405E-2
1.031E-1
5.058E-1
2 65
37 int:ARF4 ARF4 interactions 6.227E-4 1.452E-2
1.066E-1
5.374E-1
2 67
38 int:THAP1 THAP1 interactions 6.990E-4 1.587E-2
1.165E-1
6.032E-1
2 71
39 int:MIR200A MIR200A interactions 8.215E-4 1.700E-2
1.247E-1
7.090E-1
2 77
40 int:HNRNPUL2 HNRNPUL2 interactions 8.215E-4 1.700E-2
1.247E-1
7.090E-1
2 77
41 int:SUZ12 SUZ12 interactions 8.641E-4 1.700E-2
1.247E-1
7.457E-1
3 355
42 int:MIR34C MIR34C interactions 8.645E-4 1.700E-2
1.247E-1
7.461E-1
2 79
43 int:NME1 NME1 interactions 8.645E-4 1.700E-2
1.247E-1
7.461E-1
2 79
44 int:SH3GL1 SH3GL1 interactions 8.864E-4 1.700E-2
1.247E-1
7.650E-1
2 80
45 int:CBX6 CBX6 interactions 8.864E-4 1.700E-2
1.247E-1
7.650E-1
2 80
46 int:IFI16 IFI16 interactions 9.072E-4 1.702E-2
1.249E-1
7.829E-1
3 361
47 int:KIF2A KIF2A interactions 9.767E-4 1.793E-2
1.316E-1
8.429E-1
2 84
48 int:ATXN2 ATXN2 interactions 9.999E-4 1.798E-2
1.319E-1
8.630E-1
2 85
49 int:MIR141 MIR141 interactions 1.071E-3 1.887E-2
1.384E-1
9.245E-1
2 88
50 int:CEP170P1 CEP170P1 interactions 1.120E-3 1.916E-2
1.406E-1
9.666E-1
2 90
Show 45 more annotations

10: Cytoband [Display Chart] 10 input genes in category / 10 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 12q13.12-q13.13 12q13.12-q13.13 2.885E-4 2.884E-3 8.448E-3 2.885E-3 1 1
2 8q24.2 8q24.2 5.769E-4 2.884E-3 8.448E-3 5.769E-3 1 2
3 7p11 7p11 8.653E-4 2.884E-3 8.448E-3 8.653E-3 1 3
4 6q26 6q26 5.182E-3 1.295E-2 3.794E-2
5.182E-2
1 18
5 1p32 1p32 7.763E-3 1.485E-2 4.349E-2
7.763E-2
1 27
6 3q28 3q28 8.909E-3 1.485E-2 4.349E-2
8.909E-2
1 31
7 4q13.3 4q13.3 1.262E-2 1.803E-2
5.282E-2
1.262E-1
1 44
8 1p31.1 1p31.1 2.030E-2 2.537E-2
7.432E-2
2.030E-1
1 71
9 17p13.1 17p13.1 3.465E-2 3.850E-2
1.128E-1
3.465E-1
1 122
Show 4 more annotations

11: Transcription Factor Binding Site [Display Chart] 7 input genes in category / 80 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 5 input genes in category / 4 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1275 Signal transduction and activation of RNA metabolism family genenames.org 1.812E-7 7.250E-7 1.510E-6 7.250E-7 2 3

13: Coexpression [Display Chart] 10 input genes in category / 1002 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M13522 Common down-regulated transcripts in fibroblasts expressing either XP/CS or TDD mutant forms of ERCC3 [GeneID=2071], after UVC irradiation. MSigDB C2: CGP Curated Gene Sets (v6.0) 8.976E-7 8.994E-4 6.734E-3 8.994E-4 5 483
2 M7250 Up-regulated in human fetal pituitary tissue, compared to adult pituitary tissue MSigDB C2: CGP Curated Gene Sets (v6.0) 6.784E-5 1.219E-2
9.130E-2
6.797E-2
2 29
3 M5806 Genes down-regulated in comparison of untreated macrophages at 4 h versus those treated with LPS (TLR4 agonist) at 4 h. MSigDB C7: Immunologic Signatures (v6.0) 7.301E-5 1.219E-2
9.130E-2
7.316E-2
3 200
4 M5710 Genes down-regulated in comparison of ActCD4 versus WTActCD4 (see Fig. 1 in the paper for details). MSigDB C7: Immunologic Signatures (v6.0) 7.301E-5 1.219E-2
9.130E-2
7.316E-2
3 200
5 M9776 Genes up-regulated in CD8 T cells with MIR155 [GeneID=406947] knockout: resting versus activated. MSigDB C7: Immunologic Signatures (v6.0) 7.301E-5 1.219E-2
9.130E-2
7.316E-2
3 200
6 M4347 Genes up-regulated in comparison of TregLP versus TconvLP (see Table 1S in the paper for details). MSigDB C7: Immunologic Signatures (v6.0) 7.301E-5 1.219E-2
9.130E-2
7.316E-2
3 200
7 M11383 Genes up-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 16 h time point that were not up-regulated at the previous time point, 14 h. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.035E-4 1.391E-2
1.042E-1
1.038E-1
3 225
8 M15187 Cluster d6: genes progressively down-regulated in WS1 cells (fibroblast) through 18 h after irradiation with high dose UV-C. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.111E-4 1.391E-2
1.042E-1
1.113E-1
2 37
9 M15676 Genes down-regulated in a breast cancer cell line resistant to tamoxifen [PubChem=5376] compared to the parental line sensitive to the drug. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.204E-4 2.454E-2
1.837E-1
2.208E-1
2 52
10 M2700 Genes down-regulated in bone relapse of breast cancer. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.768E-4 2.774E-2
2.077E-1
2.774E-1
3 314
11 M2237 Genes down-regulated in MDA-MB-231 cells (breast cancer) upon overexpression of PARVB [GeneID=29780] under all three culture conditions. MSigDB C2: CGP Curated Gene Sets (v6.0) 3.238E-4 2.949E-2
2.208E-1
3.244E-1
2 63
12 M1871 Set 'ES exp1': genes overexpressed in human embryonic stem cells according to 5 or more out of 20 profiling studies. MSigDB C2: CGP Curated Gene Sets (v6.0) 4.804E-4 3.727E-2
2.790E-1
4.813E-1
3 379
13 M9814 Genes down-regulated in poorly differentiated thyroid carcinoma (PDTC) compared to anaplastic thyroid carcinoma (ATC). MSigDB C2: CGP Curated Gene Sets (v6.0) 4.835E-4 3.727E-2
2.790E-1
4.845E-1
2 77
14 M5275 Genes up-regulated in blood samples from bladder cancer patients. MSigDB C2: CGP Curated Gene Sets (v6.0) 5.788E-4 4.143E-2
3.102E-1
5.800E-1
3 404
Show 9 more annotations

14: Coexpression Atlas [Display Chart] 10 input genes in category / 608 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 Kidney10XCellRanger Six2KI P0 unknown unknown Overall Top 200 Genes Kidney10XCellRanger Six2KI P0 unknown unknown Overall Top 200 Genes 4.983E-5 1.515E-2
1.059E-1
3.030E-2 3 166
2 Kidney10XCellRanger Six2KI P0 unknown unknown Top 200 Kidney10XCellRanger Six2KI P0 unknown unknown Top 200 4.983E-5 1.515E-2
1.059E-1
3.030E-2 3 166

15: Computational [Display Chart] 9 input genes in category / 139 annotations before applied cutoff / 10037 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M8084 MODULE 183 RNA splicing. MSigDb: C4 - CM: Cancer Modules (v6.0) 2.118E-5 2.582E-3 1.424E-2 2.944E-3 3 65
2 M7466 MODULE 32 Genes in the cancer module 32. MSigDb: C4 - CM: Cancer Modules (v6.0) 3.716E-5 2.582E-3 1.424E-2 5.165E-3 4 241
3 M15698 GCM APEX1 Neighborhood of APEX1 MSigDb: C4 - CGN: Cancer Gene Neighborhood (v6.0) 1.141E-4 5.285E-3 2.915E-2 1.585E-2 3 114
4 M15268 MODULE 281 Phosphatase regulators. MSigDb: C4 - CM: Cancer Modules (v6.0) 2.669E-4 9.276E-3
5.116E-2
3.710E-2 2 28
5 M14741 GCM ANP32B Neighborhood of ANP32B MSigDb: C4 - CGN: Cancer Gene Neighborhood (v6.0) 4.432E-4 1.232E-2
6.796E-2
6.161E-2
2 36
6 M7638 GCM RAF1 Neighborhood of RAF1 MSigDb: C4 - CGN: Cancer Gene Neighborhood (v6.0) 6.332E-4 1.467E-2
8.091E-2
8.802E-2
2 43
Show 1 more annotation

16: MicroRNA [Display Chart] 10 input genes in category / 724 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-223:PITA hsa-miR-223:PITA TOP PITA 2.107E-8 1.264E-5 9.050E-5 1.525E-5 4 231
2 hsa-miR-1244:PITA hsa-miR-1244:PITA TOP PITA 3.490E-8 1.264E-5 9.050E-5 2.527E-5 4 262
3 hsa-miR-31-5p:TargetScan hsa-miR-31-5p TargetScan 9.443E-8 1.723E-5 1.234E-4 6.837E-5 4 336
4 hsa-miR-199a-3p:TargetScan hsa-miR-199a-3p TargetScan 1.190E-7 1.723E-5 1.234E-4 8.613E-5 4 356
5 hsa-miR-199b-3p:TargetScan hsa-miR-199b-3p TargetScan 1.190E-7 1.723E-5 1.234E-4 8.613E-5 4 356
6 hsa-miR-142-3p.2:TargetScan hsa-miR-142-3p.2 TargetScan 2.504E-7 2.109E-5 1.511E-4 1.813E-4 4 429
7 CAGTATT,MIR-200B:MSigDB CAGTATT,MIR-200B:MSigDB MSigDB 2.622E-7 2.109E-5 1.511E-4 1.898E-4 4 434
8 CAGTATT,MIR-429:MSigDB CAGTATT,MIR-429:MSigDB MSigDB 2.622E-7 2.109E-5 1.511E-4 1.898E-4 4 434
9 CAGTATT,MIR-200C:MSigDB CAGTATT,MIR-200C:MSigDB MSigDB 2.622E-7 2.109E-5 1.511E-4 1.898E-4 4 434
10 hsa-miR-493-3p:TargetScan hsa-miR-493-3p TargetScan 6.161E-7 4.461E-5 3.195E-4 4.461E-4 3 126
11 CATGTAA,MIR-496:MSigDB CATGTAA,MIR-496:MSigDB MSigDB 1.362E-6 8.967E-5 6.423E-4 9.864E-4 3 164
12 hsa-miR-4787-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.343E-6 1.414E-4 1.012E-3 1.696E-3 2 17
13 hsa-miR-654-3p:PITA hsa-miR-654-3p:PITA TOP PITA 3.246E-6 1.808E-4 1.295E-3 2.350E-3 3 219
14 GTACTGT,MIR-101:MSigDB GTACTGT,MIR-101:MSigDB MSigDB 4.379E-6 2.264E-4 1.622E-3 3.170E-3 3 242
15 hsa-miR-199a-3p:PITA hsa-miR-199a-3p:PITA TOP PITA 8.162E-6 3.693E-4 2.645E-3 5.909E-3 3 298
16 hsa-miR-199b-3p:PITA hsa-miR-199b-3p:PITA TOP PITA 8.162E-6 3.693E-4 2.645E-3 5.909E-3 3 298
17 TTGCCAA,MIR-182:MSigDB TTGCCAA,MIR-182:MSigDB MSigDB 8.834E-6 3.762E-4 2.695E-3 6.396E-3 3 306
18 hsa-miR-421:TargetScan hsa-miR-421 TargetScan 1.127E-5 4.380E-4 3.137E-3 8.160E-3 3 332
19 hsa-miR-324-3p:Functional MTI Functional MTI miRTarbase 1.189E-5 4.380E-4 3.137E-3 8.608E-3 3 338
20 hsa-miR-501-5p:PITA hsa-miR-501-5p:PITA TOP PITA 1.210E-5 4.380E-4 3.137E-3 8.761E-3 3 340
21 hsa-miR-421:PITA hsa-miR-421:PITA TOP PITA 1.376E-5 4.745E-4 3.399E-3 9.965E-3 3 355
22 hsa-miR-922:PITA hsa-miR-922:PITA TOP PITA 1.767E-5 5.604E-4 4.014E-3 1.279E-2 3 386
23 hsa-miR-155-5p:TargetScan hsa-miR-155-5p TargetScan 1.780E-5 5.604E-4 4.014E-3 1.289E-2 3 387
24 hsa-miR-222-3p:Functional MTI Functional MTI miRTarbase 1.878E-5 5.665E-4 4.058E-3 1.360E-2 3 394
25 hsa-miR-875-3p:PITA hsa-miR-875-3p:PITA TOP PITA 2.939E-5 8.512E-4 6.097E-3 2.128E-2 3 458
26 hsa-miR-182:PITA hsa-miR-182:PITA TOP PITA 3.358E-5 9.351E-4 6.698E-3 2.431E-2 3 479
27 hsa-miR-518b:mirSVR lowEffct hsa-miR-518b:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 3.769E-5 1.011E-3 7.240E-3 2.729E-2 3 498
28 hsa-miR-1227:PITA hsa-miR-1227:PITA TOP PITA 6.560E-5 1.696E-3 1.215E-2 4.749E-2 2 88
29 hsa-miR-4699-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.171E-5 1.769E-3 1.267E-2
5.192E-2
2 92
30 AACTGAC,MIR-223:MSigDB AACTGAC,MIR-223:MSigDB MSigDB 7.328E-5 1.769E-3 1.267E-2
5.306E-2
2 93
31 hsa-miR-1264:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.026E-4 2.395E-3 1.716E-2
7.426E-2
2 110
32 ATAAGCT,MIR-21:MSigDB ATAAGCT,MIR-21:MSigDB MSigDB 1.141E-4 2.581E-3 1.848E-2
8.258E-2
2 116
33 hsa-miR-1231:PITA hsa-miR-1231:PITA TOP PITA 1.932E-4 4.156E-3 2.977E-2
1.399E-1
2 151
34 GACTGTT,MIR-212:MSigDB GACTGTT,MIR-212:MSigDB MSigDB 2.009E-4 4.156E-3 2.977E-2
1.455E-1
2 154
35 GACTGTT,MIR-132:MSigDB GACTGTT,MIR-132:MSigDB MSigDB 2.009E-4 4.156E-3 2.977E-2
1.455E-1
2 154
36 hsa-miR-628-5p:PITA hsa-miR-628-5p:PITA TOP PITA 2.141E-4 4.243E-3 3.039E-2
1.550E-1
2 159
37 hsa-miR-943:PITA hsa-miR-943:PITA TOP PITA 2.168E-4 4.243E-3 3.039E-2
1.570E-1
2 160
38 hsa-miR-885-5p:PITA hsa-miR-885-5p:PITA TOP PITA 2.305E-4 4.280E-3 3.066E-2
1.669E-1
2 165
39 hsa-miR-1260:PITA hsa-miR-1260:PITA TOP PITA 2.305E-4 4.280E-3 3.066E-2
1.669E-1
2 165
40 CTACTGT,MIR-199A:MSigDB CTACTGT,MIR-199A:MSigDB MSigDB 2.447E-4 4.429E-3 3.172E-2
1.771E-1
2 170
41 hsa-miR-1197:PITA hsa-miR-1197:PITA TOP PITA 2.990E-4 5.017E-3 3.593E-2
2.165E-1
2 188
42 ACTGAAA,MIR-30E-3P:MSigDB ACTGAAA,MIR-30E-3P:MSigDB MSigDB 3.022E-4 5.017E-3 3.593E-2
2.188E-1
2 189
43 ACTGAAA,MIR-30A-3P:MSigDB ACTGAAA,MIR-30A-3P:MSigDB MSigDB 3.022E-4 5.017E-3 3.593E-2
2.188E-1
2 189
44 hsa-miR-552:PITA hsa-miR-552:PITA TOP PITA 3.054E-4 5.017E-3 3.593E-2
2.211E-1
2 190
45 CTTGTAT,MIR-381:MSigDB CTTGTAT,MIR-381:MSigDB MSigDB 3.118E-4 5.017E-3 3.593E-2
2.258E-1
2 192
46 hsa-miR-592:PITA hsa-miR-592:PITA TOP PITA 3.249E-4 5.055E-3 3.621E-2
2.352E-1
2 196
47 TTTGCAG,MIR-518A-2:MSigDB TTTGCAG,MIR-518A-2:MSigDB MSigDB 3.282E-4 5.055E-3 3.621E-2
2.376E-1
2 197
48 hsa-miR-376a:PITA hsa-miR-376a:PITA TOP PITA 3.552E-4 5.188E-3 3.716E-2
2.572E-1
2 205
49 hsa-miR-376b:PITA hsa-miR-376b:PITA TOP PITA 3.552E-4 5.188E-3 3.716E-2
2.572E-1
2 205
50 AAAGGGA,MIR-204:MSigDB AAAGGGA,MIR-204:MSigDB MSigDB 3.762E-4 5.188E-3 3.716E-2
2.724E-1
2 211
Show 45 more annotations

17: Drug [Display Chart] 10 input genes in category / 2773 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID000082127 potassium hydride Stitch 1.740E-14 4.824E-11 4.103E-10 4.824E-11 7 128
2 CID000448008 I 5 Stitch 1.758E-7 2.437E-4 2.073E-3 4.874E-4 3 27
3 CID000243583 NSC53670 Stitch 7.928E-7 6.697E-4 5.696E-3 2.198E-3 3 44
4 CID000435143 NSC-364372 Stitch 9.660E-7 6.697E-4 5.696E-3 2.679E-3 5 484
5 CID000643956 7-chloro-DL-tryptophan Stitch 4.177E-6 2.317E-3 1.970E-2 1.158E-2 3 76
6 CID000004592 olomoucine Stitch 2.198E-5 8.634E-3
7.343E-2
6.094E-2
3 132
7 CID000138490 4-aminohexanoic Acid Stitch 2.630E-5 8.634E-3
7.343E-2
7.292E-2
2 18
8 6986 UP 17-AAG; Up 200; 1uM; MCF7; HT HG-U133A Broad Institute CMAP Up 6.016E-5 8.634E-3
7.343E-2
1.668E-1
3 185
9 2296 DN Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT HG-U133A Broad Institute CMAP Down 6.513E-5 8.634E-3
7.343E-2
1.806E-1
3 190
10 4269 DN Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT HG-U133A Broad Institute CMAP Down 6.719E-5 8.634E-3
7.343E-2
1.863E-1
3 192
11 901 DN 5114445; Down 200; 10uM; MCF7; HT HG-U133A EA Broad Institute CMAP Down 6.823E-5 8.634E-3
7.343E-2
1.892E-1
3 193
12 828 DN 5252917; Down 200; 14uM; MCF7; HT HG-U133A EA Broad Institute CMAP Down 7.035E-5 8.634E-3
7.343E-2
1.951E-1
3 195
13 3254 DN Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT HG-U133A Broad Institute CMAP Down 7.035E-5 8.634E-3
7.343E-2
1.951E-1
3 195
14 1831 UP Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 7.035E-5 8.634E-3
7.343E-2
1.951E-1
3 195
15 3519 DN Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT HG-U133A Broad Institute CMAP Down 7.143E-5 8.634E-3
7.343E-2
1.981E-1
3 196
16 2740 DN Pyrithyldione [77-04-3]; Down 200; 24uM; HL60; HT HG-U133A Broad Institute CMAP Down 7.143E-5 8.634E-3
7.343E-2
1.981E-1
3 196
17 2056 DN Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT HG-U133A Broad Institute CMAP Down 7.143E-5 8.634E-3
7.343E-2
1.981E-1
3 196
18 6338 DN Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT HG-U133A Broad Institute CMAP Down 7.143E-5 8.634E-3
7.343E-2
1.981E-1
3 196
19 6273 UP Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT HG-U133A Broad Institute CMAP Up 7.252E-5 8.634E-3
7.343E-2
2.011E-1
3 197
20 4771 DN Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT HG-U133A Broad Institute CMAP Down 7.252E-5 8.634E-3
7.343E-2
2.011E-1
3 197
21 4773 DN Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT HG-U133A Broad Institute CMAP Down 7.362E-5 8.634E-3
7.343E-2
2.041E-1
3 198
22 6360 DN Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT HG-U133A Broad Institute CMAP Down 7.362E-5 8.634E-3
7.343E-2
2.041E-1
3 198
23 CID004627775 AC1NDLJ6 Stitch 7.456E-5 8.634E-3
7.343E-2
2.067E-1
2 30
24 6337 DN Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; PC3; HT HG-U133A Broad Institute CMAP Down 7.473E-5 8.634E-3
7.343E-2
2.072E-1
3 199
25 CID000004775 4-PBA Stitch 1.061E-4 1.177E-2
1.001E-1
2.943E-1
3 224
26 CID000358641 trimethoprim-sulfamethoxazole Stitch 3.646E-4 3.281E-2
2.791E-1
1.000E0
2 66
27 CID005222465 sodium butyrate Stitch 3.757E-4 3.281E-2
2.791E-1
1.000E0
3 344
28 CID003032541 e541 Stitch 4.378E-4 3.281E-2
2.791E-1
1.000E0
1 1
29 CID000006035 bromodeoxyuridine Stitch 4.873E-4 3.281E-2
2.791E-1
1.000E0
3 376
30 CID000194197 bornyl pyrophosphate Stitch 6.620E-4 3.281E-2
2.791E-1
1.000E0
2 89
31 CID003474204 VAI2 Stitch 7.856E-4 3.281E-2
2.791E-1
1.000E0
2 97
32 CID000005578 trimethoprim Stitch 8.181E-4 3.281E-2
2.791E-1
1.000E0
2 99
33 CID006450170 16-Odcya Stitch 8.754E-4 3.281E-2
2.791E-1
1.000E0
1 2
34 CID000003363 5-fluorodeoxyuridine Stitch 9.370E-4 3.281E-2
2.791E-1
1.000E0
2 106
35 CID000004158 methylphenidate Stitch 1.008E-3 3.281E-2
2.791E-1
1.000E0
2 110
36 CID005459371 1tjp Stitch 1.120E-3 3.281E-2
2.791E-1
1.000E0
2 116
37 CID000006726 cyclizine Stitch 1.120E-3 3.281E-2
2.791E-1
1.000E0
2 116
38 CID005311104 j I N Stitch 1.140E-3 3.281E-2
2.791E-1
1.000E0
2 117
39 CID000002022 acyclovir Stitch 1.279E-3 3.281E-2
2.791E-1
1.000E0
2 124
40 CID000388647 AC1L8WBM Stitch 1.513E-3 3.281E-2
2.791E-1
1.000E0
2 135
41 CID000073212 lead compounds Stitch 1.862E-3 3.281E-2
2.791E-1
1.000E0
2 150
42 4325 UP Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT HG-U133A Broad Institute CMAP Up 2.089E-3 3.281E-2
2.791E-1
1.000E0
2 159
43 CID000129126 MRTC Stitch 2.187E-3 3.281E-2
2.791E-1
1.000E0
1 5
44 2423 UP Digoxin [20830-75-5]; Up 200; 5.2uM; HL60; HT HG-U133A Broad Institute CMAP Up 2.383E-3 3.281E-2
2.791E-1
1.000E0
2 170
45 7535 DN irinotecan HCl; Down 200; 100uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.410E-3 3.281E-2
2.791E-1
1.000E0
2 171
46 1302 UP Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT HG-U133A Broad Institute CMAP Up 2.494E-3 3.281E-2
2.791E-1
1.000E0
2 174
47 958 DN resveratrol; Down 200; 10uM; MCF7; HT HG-U133A EA Broad Institute CMAP Down 2.551E-3 3.281E-2
2.791E-1
1.000E0
2 176
48 985 DN ICI 182,780; Down 200; 1uM; MCF7; HT HG-U133A EA Broad Institute CMAP Down 2.579E-3 3.281E-2
2.791E-1
1.000E0
2 177
49 3998 DN Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT HG-U133A Broad Institute CMAP Down 2.608E-3 3.281E-2
2.791E-1
1.000E0
2 178
50 4716 UP 0175029-0000 [211245-78-2]; Up 200; 1uM; MCF7; HT HG-U133A Broad Institute CMAP Up 2.608E-3 3.281E-2
2.791E-1
1.000E0
2 178
Show 45 more annotations

18: Disease [Display Chart] 9 input genes in category / 92 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C3274463 Sickle Beta 0 Thalassemia DisGeNET BeFree 5.554E-4 3.809E-2
1.944E-1
5.110E-2
1 1
2 C2363903 Angiocentric glioma DisGeNET Curated 1.110E-3 3.809E-2
1.944E-1
1.022E-1
1 2
3 C0016667 Fragile X Syndrome DisGeNET Curated 1.242E-3 3.809E-2
1.944E-1
1.143E-1
2 97
4 C1335712 Medulloblastoma recurrent DisGeNET BeFree 1.665E-3 3.830E-2
1.955E-1
1.532E-1
1 3
5 20090713:International Schizophrenia Consortium Schizophrenia GWAS 2.220E-3 4.085E-2
2.085E-1
2.042E-1
1 4
6 C0750979 Primary malignant neoplasm of brain DisGeNET BeFree 2.774E-3 4.254E-2
2.171E-1
2.552E-1
1 5
7 C1519086 Pilomyxoid astrocytoma DisGeNET BeFree 3.328E-3 4.374E-2
2.233E-1
3.062E-1
1 6
Show 2 more annotations